Stefan Karl-Heinz Pflanz

Title: The Innovations of Stefan Karl-Heinz Pflanz

Introduction

Stefan Karl-Heinz Pflanz is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of cytokine-related reagents and diagnostic methods. With a total of 5 patents, his work has had a considerable impact on medical research and therapeutic applications.

Latest Patents

Among his latest patents are "Binding compounds for IL-27" and "IL-D80 polynucleotides." The first patent provides purified genes encoding a cytokine or composite cytokine from a mammal, along with reagents such as purified proteins, specific antibodies, and nucleic acids. It also includes methods for using these reagents and diagnostic kits. Similarly, the second patent focuses on purified genes encoding a cytokine or composite cytokine, offering related reagents and methods for their application in diagnostics.

Career Highlights

Stefan has worked with prominent companies in the pharmaceutical industry, including Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to collaborate on various innovative projects that advance the understanding and treatment of diseases.

Collaborations

Some of his notable coworkers include Jacqueline C Timans and Robert A Kastelein. Their collaborative efforts have contributed to the successful development of his patented technologies.

Conclusion

Stefan Karl-Heinz Pflanz's work exemplifies the spirit of innovation in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving diagnostic methods. His contributions continue to influence the field and inspire future research.